Altered Folate Metabolism and Disposition in Mothers Affected by a Spina Bifida Pregnancy: Influence of 677c → t Methylenetetrahydrofolate Reductase and 2756a → g Methionine Synthase Genotypes

This publication has 29 references indexed in Scilit:

• A Common Variant in Methionine Synthase Reductase Combined with Low Cobalamin (Vitamin B12) Increases Risk for Spina Bifida
  Molecular Genetics and Metabolism, 1999
• Impaired Regeneration of Monoglutamyl Tetrahydrofolate Leads to Cellular Folate Depletion in Mothers Affected by a Spina Bifida Pregnancy
  Molecular Genetics and Metabolism, 1998
• Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria
  Proceedings of the National Academy of Sciences, 1998
• Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate‐dehydrogenase, methenyltetrahydrofolate‐cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects
  Clinical Genetics, 1998
• Methionine synthase and neural tube defects.
  Journal of Medical Genetics, 1997
• Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
  The Lancet, 1995
• A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group.
  Archives of Disease in Childhood, 1992
• Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
  Published by Elsevier ,1991
• FURTHER EXPERIENCE OF VITAMIN SUPPLEMENTATION FOR PREVENTION OF NEURAL TUBE DEFECT RECURRENCES
  The Lancet, 1983
• Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects.
  BMJ, 1981